Paolo Martelletti | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
What is changing in chronic migraine treatment? An algorithm for onabotulinumtoxinA treatment by the Italian chronic migraine group	EXPERT REVIEW OF NEUROTHERAPEUTICS	2020
"Triaging" Chronic Migraine Patients in Need of CGRP(r) Monoclonal Antibodies	PAIN AND THERAPY	2020
Atogepant. Calcitonin gene-related peptide (CGRP) receptor antagonist, Preventive treatment of migraine	DRUGS OF THE FUTURE	2020
Incidence and determinants of high-sensitivity troponin and natriuretic peptides elevation at admission in hospitalized COVID-19 pneumonia patients	INTERNAL AND EMERGENCY MEDICINE	2020
Novel synthetic treatment options for migraine	EXPERT OPINION ON PHARMACOTHERAPY	2020
Rimegepant for the treatment of migraine	DRUGS OF TODAY	2020
Position paper on post-traumatic headache. The relationship between head trauma, stress disorder, and migraine	PAIN AND THERAPY	2020
Illness perception and job satisfaction in patients suffering from migraine headaches. Trait anxiety and depressive symptoms as potential mediators	HEADACHE	2019
Development and validation of the ID-EC - The ITALIAN version of the identify chronic migraine	THE JOURNAL OF HEADACHE AND PAIN	2019
How do you choose the appropriate migraine pharmacotherapy for an elderly person?	EXPERT OPINION ON PHARMACOTHERAPY	2019
Migraine and cluster headache show impaired neurosteroids patterns	THE JOURNAL OF HEADACHE AND PAIN	2019
Fremanezumab for the preventive treatment of migraine in adults	EXPERT REVIEW OF CLINICAL PHARMACOLOGY	2019
Rimegepant. calcitonin gene-related peptide (CGRP) receptor antagonist, treatment of migraine	DRUGS OF THE FUTURE	2019
Patient selection for migraine preventive treatment with anti-CGRP(r) monoclonal antibodies	EXPERT REVIEW OF NEUROTHERAPEUTICS	2019
Gepants for the treatment of migraine	EXPERT OPINION ON INVESTIGATIONAL DRUGS	2019
Profiling lasmiditan as a treatment option for migraine	EXPERT OPINION ON PHARMACOTHERAPY	2019
Cost of chronic and episodic migraine patients in continuous treatment for two years in a tertiary level headache Centre	THE JOURNAL OF HEADACHE AND PAIN	2019
The future of pharmacogenetics in the treatment of migraine	PHARMACOGENOMICS	2019
Job satisfaction mediates the association between perceived disability and work productivity in migraine headache patients	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH	2019
Current and emerging evidence-based treatment options in chronic migraine. a narrative review	THE JOURNAL OF HEADACHE AND PAIN	2019